Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

Back

ESC Premium Access

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

Session: Poster Session 5 - Atrial fibrillation - Stroke prevention 3

Topic: Oral Anticoagulation

Speaker: Doctor T. Chao (Taipei, TW)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

4 presentations

0 follower

9 more presentations in this session

Comparison of ischemic stroke risk in atrial fibrillation patients with or without myocardial infarction: A propensity score matched study

Speaker: Doctor G. Yoon (Incheon, KR)

Access

Abstract

Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure

Speaker: Doctor C. Coleman (Storrs, US)

Access

Abstract

Slides

Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice: a subanalysis of the FANTASIIA registry, a prospective, nationwide, real-world, observational study.

Speaker: Doctor M. Ruiz Ortiz (Cordoba, ES)

Access

Abstract

Slides

Incidence of incomplete surgical left atrial appendage closure

Speaker: Assistant Professor Y. Kim (GangNeung, KR)

Access

Abstract

Slides

The individual stroke risk in patients with atrial fibrillation

Speaker: Doctor C. Lee (Copenhagen, DK)

Access

Abstract

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 3

Speakers: Doctor T. Chao, Doctor G. Yoon, Doctor C. Coleman, Doctor M. Ruiz Ortiz, Assistant Professor Y. Kim...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources